Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000912057-02-017889
Filing Date
2002-05-01
Accepted
2002-05-01 14:35:53
Documents
8
Period of Report
2002-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a2078193z10-q.htm 10-Q 97150
3 EXHIBIT 10.1 a2078193zex-10_1.htm EX-10.1 190638
4 EXHIBIT 10.2 a2078193zex-10_2.htm EX-10.2 37772
5 EXHIBIT 10.3 a2078193zex-10_3.htm EX-10.3 11981
6 EXHIBIT 10.4 a2078193zex-10_4.htm EX-10.4 13948
7 EXHIBIT 10.5 a2078193zex-10_5.htm EX-10.5 28787
8 EXHIBIT 10.6 a2078193zex-10_6.htm EX-10.6 39832
9 EXHIBIT 10.7 a2078193zex-10_7.htm EX-10.7 22499
  Complete submission text file 0000912057-02-017889.txt   444903
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GENZYME TRANSGENICS CORP (Filer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
Type: 10-Q | Act: 34 | File No.: 000-21794 | Film No.: 02629685
SIC: 2836 Biological Products, (No Diagnostic Substances)